No Detail Found!

Exosomes promote lymph node metastasis by CD133 interaction with VEGFR3 in thyroid cancer cells

Author(s)
Xinyou Liu Department of General Surgery, Zhongshan Hospital (Xiamen), Fudan University, Xiamen 361015, China; Xiamen Clinical Research Center for Cancer Therapy, Xiamen 361015, China
Yihong Luo Department of General Surgery, Zhongshan Hospital, Fudan University,Shanghai, 200032,China
Zhenglin Wang Department of General Surgery, Zhongshan Hospital, Fudan University,Shanghai, 200032,China
Cong Wang Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, China; Department of General Surgery, Zhongshan Hospital (Xiamen), Fudan University, Xiamen 361015, China; Xiamen Clinical Research Center for Cancer Therapy, Xiamen 361015, China
Abstract
This study addresses a critical knowledge gap in understanding the tumor microenvironment of thyroid cancer by elucidating the mechanism by which tumor cell-derived CD133-positive exosomes promote lymph node metastasis. We employed molecular docking, western blot, and other molecular characterizations to investigate the crucial interaction between CD133 and VEGFR3 and its impact on metastasis. Additionally, experiments assessed the influence of CD133-positive exosomes on lymphatic endothelial cell proliferation and migration. Our findings demonstrate a significant direct interaction between CD133 and VEGFR3, as suggested by molecular docking. Furthermore, inhibition of CD133 expression resulted in a notable reduction in lymph node metastasis. We also observed that CD133-positive exosomes derived from thyroid cancer cells actively contribute to the migration and proliferation of lymphatic endothelial cells. These results unveil a novel pathway for lymph node metastasis in thyroid cancer. The identification of CD133 and its interaction with VEGFR3 as key players in this process holds significant promise for the development of targeted therapeutic strategies. By focusing on these targets, researchers can potentially improve the prognosis of patients with thyroid cancer.
Publication Details
Page(s) 1-14
Published Journal: Asian Journal of Agriculture and Biology, Volume: 4, Issue: 0, Year: 2024

Request the full text from PASTIC

Keywords
VEGFR3, Lymph node metastasis, Exomes, CD133, Thyroid cancer cells
References
Alitalo K and Carmeliet P .2002 .Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell, 1 : 219-227.
Altschul SF,Madden TL,Schäffer AA,Zhang J,Zhang Z,Miller W,Lipman DJ .1997 .Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res, 25 : 3389-3402.
Carrasco-Ramírez P,Greening DW,Andrés G,Gopal SK,Martín-Villar E,Renart J,Simpson RJ,Quintanilla M .2016 .Podoplanin is a component of extracellular vesicles that reprograms cellderived exosomal proteins and modulates lymphatic vessel formation. Oncotarget, 7 : 16070.
Yeates Colovos C,TO Colovos C .1993 .Verification of protein structures: patterns of nonbonded atomic interactions. Protein Sci, 2 : 1511-1519.
Dionigi G,Dionigi R,Bartalena L,Boni L,Rovera F,Villa F .2006 .Surgery of lymph nodes in papillary thyroid cancer. Expert Rev. Anticancer Ther, 6 : 1217-1229.
Elaraj DM,Sturgeon C .2009 .Adequate surgery for papillary thyroid cancer. The Surgeon, 7 : 286-289.
Duhovny D,Nussinov R,Wolfson HJ .2002 .Efficient unbound docking of rigid molecules Algorithms. Proceedings, 2 : 185-200.
Friedman S,Lu M,Schultz A,Thomas D,Lin RY .2009 .CD133+ anaplastic thyroid cancer cells initiate tumors in immunodeficient mice and are regulated by thyrotropin. PloS One, 4 : e5395.
Hood JL,San RS,Wickline SA .2011 .Exosomes Released by Melanoma Cells Prepare Sentinel Lymph Nodes for Tumor Metastasis Melanoma Exosome Preparation of Lymph Nodes for Metastasis. Cancer Res, 71 : 3792-3801.
Jiang X,Nicolls MR,Tian W,Rockson SG .2018 .Lymphatic dysfunction, leukotrienes, and lymphedema. Annu. Rev. Physiol, 80 : 49.
Karnezis T,Shayan R,Caesar C,Roufail S,Harris NC,Ardipradja K,Zhang YF,Williams SP,Farnsworth RH,Chai MG .2012 .VEGF-D promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endothelium. Cancer Cell, 21 : 181-195.
Ke CC,Liu RS,Yang AH,Liu CS,Chi CW,Tseng LM,Tsai YF,Ho JH,Lee CH,Lee OK .2013 .-expressing thyroid cancer cells are undifferentiated, radioresistant and survive radioiodide therapy. Eur. J. Nucl. Med. Mol. Imaging, 40 : 61-71.
Kluijfhout WP,Drake FT,Pasternak JD,Beninato T,Vriens MR,Shen WT,Gosnell JE,Liu C,Suh I,Duh QY .2017 .Incidental positive lymph nodes in patients with papillary thyroid cancer is independently associated with recurrent disease. J. Surg. Oncol, 116 : 275-280.
Koyama-Nasu R,Takahashi R,Yanagida S,NasuNishimura Y,Oyama M,Kozuka-Hata H,Haruta R,Manabe E,Hoshino-Okubo A,Omi H .2013 .The cancer stem cell marker CD133 interacts with plakoglobin and controls desmoglein-2 protein levels. PLoS One, 8 : e53710.
Liu Y,Cao X .2016 .Characteristics and significance of the pre-metastatic niche. Cancer Cell, 30 : 668-681.
Liu Y,Li Y,Wang Y,Lin C,Zhang D,Chen J,Ouyang L,Wu F,Zhang J,Chen L .2022 .Recent progress on vascular endothelial growth factor receptor inhibitors with dual targeting capabilities for tumor therapy. J. Hematol. Oncol, 15(1) : 89.
Lucchetti D,Calapà F,Palmieri V,Fanali C,Carbone F,Papa A,De Maria R,De Spirito M and Sgambato A .2017 .Differentiation affects the release of exosomes from colon cancer cells and their ability to modulate the behavior of recipient cells. Am. J. Pathol, 187 : 1633-1647.
Mak AB,Nixon AM,Kittanakom S,Stewart JM,Chen GI,Curak J,Gingras AC,Mazitschek R,Neel BG,Stagljar I .2012 .Regulation of CD133 by HDAC6 promotes β-catenin signaling to suppress cancer cell differentiation. Cell Rep, 2 : 951-963.
Mashiach E,Schneidman-Duhovny D,Andrusier N,Nussinov R,Wolfson HJ .2008 .FireDock: a web server for fast interaction refinement in molecular docking. Nucleic Acids Res, 36 : W229-232.
Monzani E,Facchetti F,Galmozzi E,Corsini E,Benetti A,Cavazzin C,Gritti A,Piccinini A,Porro D,Santinami M .2007 .Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential. Eur. J. Cancer, 43 : 935-946.
Nabet BY,Qiu Y,Shabason JE,Wu TJ,Yoon T,Kim BC,Benci JL,DeMichele AM,Tchou J,Marcotrigiano J .2017 .Exosome RNA unshielding couples stromal activation to pattern recognition receptor signaling in cancer. Cell, 170 : 352-366.
Neuzil J,Stantic M,Zobalova R,Chladova J,Wang X,Prochazka L,Dong L,Andera L,Ralph SJ .2007 .Tumour-initiating cells vs. cancer 'stem'cells and CD133: what's in the name. Biochem. Biophys. Res. Commun, 355 : 855-859.
O'Brien CA,Pollett A,Gallinger S,Dick JE .2007 .A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature, 445 : 106-110.
Patel SA,Nilsson MB,Le X,Cascone T,Jain RK,Heymach JV .2023 .Molecular Mechanisms and Future Implications of VEGF/VEGFR in Cancer Therapy. Clin. Cancer Res, 29 : 30-39.
Pettersen EF,Goddard TD,Huang CC,Couch GS,Greenblatt DM,Meng EC,Ferrin TE .2004 .UCSF Chimera-a visualization system for exploratory research and analysis. J. Comput. Chem, 25 : 1605-1612.
Pospieszna J,Dams-Kozlowska H,Udomsak W,Murias M,Kucinska M .2023 .Unmasking the Deceptive Nature of Cancer Stem Cells: The Role of CD133 in Revealing Their Secrets. Int. J. Mol. Sci, 24 : 10910.
Rappa G,Mercapide J,Anzanello F,Pope RM,Lorico A .2013 .Biochemical and biological characterization of exosomes containing prominin-1/CD133. Mol. Cancer, 12 : 62.
Ricci-Vitiani L,Lombardi DG,Pilozzi E,Biffoni M,Todaro M,Peschle C,De Maria R C .2007 .Identification and expansion of human coloncancer-initiating cells. Nature, 445 : 111-115.
Rose PW,Beran B,Bi C,Bluhm WF,Dimitropoulos D,Goodsell DS,Prlić A,Quesada M,Quinn GB,Westbrook JD .2010 .The RCSB Protein Data Bank: redesigned website and web services. Nucleic Acids Res, 39 : D392-401.
Roy A,Kucukural A,Zhang Y .2010 .I-TASSER: a unified platform for automated protein structure and function prediction. Nat. Protoc, 5 : 725-738.
Schneidman-Duhovny D,Inbar Y,Nussinov R,Wolfson HJ .2005 .PatchDock and SymmDock: servers for rigid and symmetric docking. Nucleic Acids Res, 33 : W363-367.
Singh SK,Hawkins C,Clarke ID,Squire JA,Bayani J,Hide T,Henkelman RM,Cusimano MD,Dirks PB .2004 .Identification of human brain tumour initiating cells. Nature, 432 : 396-401.
Tai YL,Chu PY,Lee BH,Chen KC,Yang CY,Kuo WH,Shen TL .2019 .Basics and applications of tumor-derived extracellular vesicles. J. Biomed. Sci, 26 : 1-17.
Wei Y,Jiang Y,Zou F,Liu Y,Wang S,Xu N,Xu W,Cui C,Xing Y,Liu Y .2013 .Activation of PI3K/Akt pathway by CD133-p85 interaction promotes tumorigenic capacity of glioma stem cells. Proc. Natl. Acad. Sci, 110 : 6829-6834.
Whiteside TL .2016 .Tumor-derived exosomes and their role in cancer progression. Adv. Clin. Chem, 74 : 103-141.
Yin AH,Miraglia S,Zanjani ED,Almeida-Porada G,Ogawa M,Leary AG,Olweus J,Kearney J,Buck DW .1997 .AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood, 90 : 5002-5012.
Zhan L,Feng H,Yu X,Li L,Song J,Tu Y,Yuan J,Chen C,Sun S .2022 .Clinical and prognosis value of the number of metastatic lymph nodes in patients with papillary thyroid carcinoma. BMC Surg, 22 : 235.
Zhang H,Deng T,Liu R,Bai M,Zhou L,Wang X,Li S,Wang X,Yang H,Li J .2017 .Exosomedelivered EGFR regulates liver microenvironment to promote gastric cancer liver metastasis. Nat. Commun, 8 : 1-11.
Zito G,Richiusa P,Bommarito A,Carissimi E,Russo L,Coppola A,Zerilli M,Rodolico V,Criscimanna A,Amato M .2008 .In vitro identification and characterization of CD133pos cancer stem-like cells in anaplastic thyroid carcinoma cell lines. PLoS One, 3 : e3544.
0

Citations

0

Downloads

9

Views